Moderna Recursion: Which Cutting-Edge Path Is Best in 2026
Two biotech powerhouses take very different routes: Moderna builds medicines with mRNA, while Recursion uses machine ...
Flexible budgets empower you to adjust spending as circumstances shift, strengthening your overall planning and helping you stay on track toward financial goals.
21,409 articlesTwo biotech powerhouses take very different routes: Moderna builds medicines with mRNA, while Recursion uses machine ...
A federal judge dismissed the Binance terrorism lawsuit, citing lack of direct links to specific attacks. The ruling ...
OP Labs reports a turning point for crypto monetization as exchange-owned stack chains made a near-$500 million oncha...
A rare historical market signal has flashed across the investing world. This article breaks down what it might mean f...
Plaid has integrated its Home Lending Report into ICE Mortgage Technology’s Encompass, embedding asset verification i...
Beeline Holdings signaled a strategic move to buy the remaining stake in AI tech firm MagicBlocks, aiming to turn it ...
Vertex Pharmaceuticals has climbed to fresh highs, fueled by a robust cystic fibrosis portfolio and strong cash flow....
Three ETFs with yields above 10% are drawing attention in March 2026, each using a different mechanism to pay out hig...
OKX is investing $53 million for a 20% stake in Coinone, a move that broadens its footprint in South Korea’s competit...
A coalition of housing groups is pressing the FHFA to delay and rewrite proposed condo-loan changes from Fannie Mae a...
UK tax authorities plan to buy crypto forensic tools to pursue digital asset tax fraud. The move signals a broader pu...
A mobile app rewards users for scrolling, propelling Mode Mobile into Deloitte’s fastest-growing software roster. Sha...